Abstract
Lacosamide (LCM) is anticonvulsant in animal models and is in phase 3 assessment for epilepsy and neuropathic pain. Here we seek to identify cellular actions for the new drug and effects on recognised target sites for anticonvulsant drugs. Radioligand binding and electrophysiology were used to study the effects of LCM at well-established mammalian targets for clinical anticonvulsants. 10 microM LCM did not bind with high affinity to a plethora of rodent, guinea pig or human receptor sites including: AMPA; Kainate; NMDA (glycine/PCP/MK801); GABA(A) (muscimol/benzodiazepine); GABA(B); adenosine A1,2,3; alpha1, alpha2; beta1, beta2; M1,2,3,4,5; H1,2,3; CB1,2; D1,2,3,4,5; 5HT1A,1B,2A,2C,3,5A,6,7 and KATP. Weak displacement (25%) was evident at batrachotoxin site 2 on voltage gated Na+ channels. LCM did not inhibit neurotransmitter transport mechanisms for norepinephrine, dopamine, 5-HT or GABA, nor did it inhibit GABA transaminase. LCM at 100 microM produced a significant reduction in the incidence of excitatory postsynaptic currents (EPSC's) and inhibitory postsynaptic currents (IPSC's) in cultured cortical cells and blocked spontaneous action potentials (EC50 61 microM). LCM did not alter resting membrane potential or passive mem...Continue Reading
References
Jan 22, 1979·Life Sciences·R C SpethH I Yamamura
May 1, 1979·European Journal of Pharmacology·P Greengrass, R Bremner
Jun 1, 1978·Nature·S R Snodgrass
Jul 9, 1992·Nature·H H Van TolV Jovanovic
Feb 26, 1991·European Journal of Pharmacology·M TrampusP A Borea
Jan 1, 1991·Fundamental & Clinical Pharmacology·I Angel, S Bidet
Jan 3, 1991·European Journal of Pharmacology·M A SillsM Williams
Nov 1, 1991·Pharmacology & Toxicology·S Uhlén, J E Wikberg
Apr 25, 1990·European Journal of Pharmacology·J M ArrangJ C Schwartz
Apr 18, 1991·Nature·R K SunaharaH B Niznik
May 1, 1991·Agents and Actions·S DiniG Clavenna
Aug 9, 1990·Nature·L A MatsudaT I Bonner
Sep 6, 1990·Nature·Q Y ZhouO Civelli
Mar 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M RuatW Schunack
Aug 14, 1989·Neuroscience Letters·K MuraseM Randic
Dec 7, 1989·European Journal of Pharmacology·M TeraiY Nakamura
Feb 1, 1988·Antimicrobial Agents and Chemotherapy·A TsujiH Kato
Sep 1, 1988·Brain Research Bulletin·R W SchererS J Enna
Jan 20, 1987·European Journal of Pharmacology·A C Foster, G E Fagg
Sep 1, 1987·Neurochemical Research·D E MurphyM Williams
Oct 14, 1985·FEBS Letters·M E GoldmanS M Paul
Nov 26, 1985·European Journal of Pharmacology·D HoyerH O Kalkman
Jul 16, 1986·Brain Research·J VignonR Chicheportiche
Sep 1, 1986·Epilepsia·M J LeachA A Miller
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Dec 2, 1982·Brain Research·D T Monaghan, C W Cotman
Jun 1, 1995·British Journal of Pharmacology·D W BonhausR M Eglen
May 28, 1993·Brain Research·G Lees, M J Leach
Sep 2, 1993·Nature·S MunroM Abu-Shaar
May 19, 1995·The Journal of Biological Chemistry·J C McPheeW A Catterall
Dec 23, 1994·Journal of Medicinal Chemistry·P BardelH Kohn
Jan 1, 1994·European Journal of Pharmacology·R G MacKenzieK L O'Malley
Dec 5, 1994·FEBS Letters·S ReesM Lee
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C A SalvatoreR G Johnson
Aug 1, 1993·Journal of Neuroscience Research·G J BrewerP J Price
Dec 1, 1995·Journal of Neuroscience Research·G J Brewer
Apr 26, 1996·Journal of Medicinal Chemistry·D ChoiH Kohn
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·D S RagsdaleW A Catterall
Jul 1, 1996·British Journal of Pharmacology·A G HopeT P Blackburn
Feb 1, 1997·Journal of Neuroscience Methods·G J Brewer
May 1, 1997·Epilepsia·C Zona, M Avoli
Aug 15, 1997·Neuroscience Letters·C ZonaM Avoli
Jan 24, 1998·European Journal of Pharmacology·C Rundfeldt
May 26, 1998·Brain Research. Brain Research Reviews·D S Ragsdale, M Avoli
Jun 18, 1999·Cardiovascular Drugs and Therapy·C Smith, M Teitler
Jan 13, 2000·Bioorganic & Medicinal Chemistry·S V AndurkarH Kohn
Mar 14, 2000·Neuroscience Letters·C Rundfeldt, R Netzer
Aug 30, 2000·Neuropharmacology·M O Cunningham, R S Jones
Mar 17, 2001·Nature Reviews. Neuroscience·T J Jentsch
Jul 13, 2001·Pharmacology & Therapeutics·P KwanM J Brodie
Citations
Jan 3, 2012·Archives of Pharmacal Research·Tae-Sung KooHongsik Moon
Nov 10, 2013·CNS Drugs·Sheridan M Hoy
Jan 3, 2007·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Pamela DotyDirk Thomas
Jul 10, 2010·Journal of Medicinal Chemistry·Pierre MorieuxHarold Kohn
Jan 1, 2010·Nature Reviews. Drug Discovery·Meir Bialer, H Steve White
Jun 12, 2010·The Journal of Biological Chemistry·Yuying WangRajesh Khanna
Nov 23, 2006·Epilepsia·Claudia BrandtWolfgang Löscher
Feb 3, 2009·Epilepsia·Péter HalászUNKNOWN SP755 Study Group
Oct 14, 2011·Epilepsia·Eugen Trinka
Apr 28, 2009·Epilepsy Currents·Jonathan J Halford, Marc Lapointe
Feb 8, 2007·Arthritis Research & Therapy·Bettina BeyreutherThomas Stöhr
Jun 1, 2010·Continuum : Lifelong Learning in Neurology·William O Tatum
May 12, 2012·Anesthesia and Analgesia·Otilia ObrejaMartin Schmelz
Oct 10, 2009·Therapeutics and Clinical Risk Management·Christoph Kellinghaus
Mar 28, 2009·Drugs·Sarah A Cross, Monique P Curran
Jun 26, 2009·CNS Drugs·Giulia CuriaMassimo Avoli
Jan 12, 2013·Future Neurology·Rajesh KhannaKenneth Hensley
Mar 16, 2007·Neuropharmacology·Bettina K BeyreutherClaudia Sommer
Oct 1, 2014·Pediatric Neurology·Ismail PashaSuresh K Didagi
Aug 10, 2012·Expert Opinion on Pharmacotherapy·Alberto VerrottiGaetano Zaccara
Dec 24, 2008·Expert Review of Neurotherapeutics·Ahmad BeydounPamela Doty
Sep 4, 2015·Expert Opinion on Pharmacotherapy·Caterina PalleriaEmilio Russo
Nov 14, 2007·Expert Review of Neurotherapeutics·Theodore R Cummins, Anthony M Rush
Aug 7, 2010·Expert Opinion on Investigational Drugs·Gary McCleane
Aug 7, 2012·Expert Opinion on Emerging Drugs·Luana LionettoPaolo Martelletti
Sep 19, 2007·Expert Opinion on Emerging Drugs·Patrick Kwan, Martin J Brodie
Mar 3, 2012·Annals of Medicine·G L KraussB Lin
May 16, 2009·Pharmacological Reports : PR·Jarogniew J Luszczki
Mar 16, 2016·Pharmacological Reports : PR·Magdalena Bujalska-ZadrożnyPatrycja Kleczkowska
Feb 5, 2013·Trends in Pharmacological Sciences·Boris S Zhorov, Denis B Tikhonov
Mar 22, 2012·Neuroscience·S M WilsonR Khanna
Mar 17, 2011·Epilepsy & Behavior : E&B·M GavathaA S Papavasiliou
Mar 20, 2010·Lancet Neurology·Massimo MantegazzaMassimo Avoli
Nov 26, 2015·CNS Drugs·Sima I PatelIlo E Leppik
Jan 20, 2009·Brain Research Reviews·Sulayman D Dib-HajjKatharina Zimmermann
Dec 30, 2008·Brain Research Bulletin·Ben A ChindoKarniyus S Gamaniel
Dec 3, 2008·Medical Hypotheses·Matt T BianchiSydney S Cash
Nov 15, 2008·Epilepsy Research·Meir BialerH Steve White
Nov 26, 2015·Frontiers in Pharmacology·Cedric J LaedermannIsabelle Decosterd
Apr 17, 2007·Epilepsy Research·Thomas StöhrH Steve White
Mar 31, 2007·European Journal of Pharmacology·Bettina K BeyreutherThomas Stöhr
Nov 26, 2015·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Ismail PashaD K Suresh
Jul 20, 2007·Epilepsia·Elinor Ben-MenachemG David Rudd
Apr 28, 2007·CNS Drug Reviews·Bettina K BeyreutherThomas Stöhr
Jun 19, 2013·Epilepsia·Maxine DibuéToni Schneider
May 4, 2011·Journal of Neuroscience Research·Brad A SutherlandIan Appleton
Jan 9, 2013·Epilepsia·Julia Höfler, Eugen Trinka
Jun 12, 2013·Epilepsia·Alexey ShandraThomas Stöhr
Jul 8, 2011·Biomedical Chromatography : BMC·Soo-Jin KimHongsik Moon
May 2, 2015·Pharmacology, Biochemistry, and Behavior·Shraddha R BangPrashant D Ambavade